Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective Study to Characterise and Assess Clinical Outcomes of Patients Receiving Benralizumab After Marketing Approval in Spain.

NCT04648839 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04648839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04648839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective Study to Characterise and Assess Clinical Outcomes of Patients Receiving Benralizumab After Marketing Approval in Spain.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 16, 2021
Completion date
July 16, 2021
Enrollment
221 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma